首次就诊泡沫硬化剂治疗启动静脉性溃疡愈合的十年经验
该回顾性比较研究纳入2009年12月至2019年10月Oulu大学医院的245处静脉性溃疡(214例患者),比较首次就诊泡沫硬化剂治疗(A组143处)与预约治疗(B组102处)对溃疡愈合的影响。主要结局为溃疡愈合时间,A组中位愈合时间2.3个月,B组3.2个月(P=.002)。结论支持首次就诊泡沫硬化剂治疗可有效启动静脉内消融以促进溃疡愈合,并应尽量避免延迟消融。
要点
- 首次就诊泡沫硬化剂组溃疡愈合中位时间2.3个月,短于预约治疗组的3.2个月(P=.002)。
- 转诊后延迟启动静脉内消融超过2个月者,中位愈合时间延长至5.0个月(P=.002)。
- 两组溃疡复发率分别为7.7%与11.8%,差异无统计学意义(P=.281)。
核心结论
- 首次就诊泡沫硬化剂治疗是启动静脉内消融以促进静脉性溃疡愈合的有效方法。
- 静脉性溃疡应尽可能避免延迟静脉内消融。
研究设计与样本
- 回顾性比较研究,纳入2009年12月至2019年10月Oulu大学医院的245处静脉性溃疡(214例患者,含复发性溃疡)。
- A组143处接受首次就诊泡沫硬化剂治疗,B组102处接受预约治疗;所有患者均接受静脉内消融(泡沫硬化剂和/或热消融)及压力治疗。
- 主要结局为溃疡愈合间隔时间,采用Kaplan-Meier生存分析;次要结局包括转诊后至溃疡愈合时间及溃疡复发。
主要发现
- A组溃疡愈合中位时间为2.3个月,B组为3.2个月(P=.002)。
- 转诊后首次静脉内消融延迟<1个月、1至2个月、>2个月者的估计中位溃疡愈合时间分别为2.7、3.3、5.0个月(P=.002)。
- A组11例患者(7.7%)记录到复发性溃疡,B组12例(11.8%;P=.281)。
临床怎么用
- 对静脉性溃疡患者可考虑首次就诊即行泡沫硬化剂治疗以启动静脉内消融,促进溃疡愈合。
- 应尽量避免延迟静脉内消融,以缩短溃疡愈合时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated the effect of first-visit foam sclerotherapy compared with scheduled treatment for patients with venous ulceration. METHODS: The study design was a retrospective comparative study. From December 2009 to October 2019, a total of 245 venous ulcers in 214 patients (including recurrent ulcers) were treated at Oulu University Hospital. Of these 245 venous ulcers, 143 were treated with first-visit foam sclerotherapy (group A) and 102 with scheduled treatment (group B). All patients received endovenous ablation (foam sclerotherapy and/or endothermal ablation) and compression therapy to promote venous ulcer healing. The primary outcome was the interval to ulcer healing, determined by Kaplan-Meier survival analysis. The secondary outcomes included the time to ulcer healing from the receipt of referral and ulcer recurrence. RESULTS: The median time to ulcer healing was 2.3 months for group A and 3.2 months for group B (P = .002). The estimated median ulcer healing times after referral for a first session of endovenous ablation were 2.7 months with a delay of <1 month from the referral, 3.3 months with a delay of 1 to 2 months, and 5.0 months with a delay of >2 months (P = .002). In group A, recurrent ulcers were recorded for 11 patients (7.7%). In group B, recurrent ulcers were recorded for 12 patients (11.8%; P = .281). CONCLUSIONS: The results of the present retrospective comparative study support first-visit foam sclerotherapy as an effective method to initiate endovenous ablation to promote venous ulcer healing. In venous ulcers, delays to endovenous ablation should be avoided whenever possible.
引用
- Pihlaja T, Torro P, Ohtonen P, et al. Ten years of experience with first-visit foam sclerotherapy to initiate venous ulcer healing. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33248300. doi:10.1016/j.jvsv.2020.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。